Rock Springs Capital Management LP Sells 192,000 Shares of SPDR S&P Biotech ETF $XBI

Rock Springs Capital Management LP decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 86.5% during the first quarter, Holdings Channel.com reports. The institutional investor owned 30,000 shares of the exchange traded fund’s stock after selling 192,000 shares during the quarter. Rock Springs Capital Management LP’s holdings in SPDR S&P Biotech ETF were worth $3,832,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Financial Life Planners bought a new position in SPDR S&P Biotech ETF during the 1st quarter worth about $27,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC purchased a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $27,000. Intesa Sanpaolo Wealth Management bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $30,000. SHP Wealth Management bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $31,000. Finally, Legacy Wealth Managment LLC ID bought a new stake in shares of SPDR S&P Biotech ETF in the 4th quarter valued at about $32,000.

SPDR S&P Biotech ETF Stock Performance

Shares of XBI opened at $150.59 on Tuesday. The company has a 50 day moving average price of $144.70 and a 200-day moving average price of $133.73. SPDR S&P Biotech ETF has a fifty-two week low of $84.39 and a fifty-two week high of $165.71. The stock has a market capitalization of $10.14 billion, a PE ratio of 11.47 and a beta of 0.82.

SPDR S&P Biotech ETF Company Profile

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.

Featured Stories

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.